Review confirms that antidepressants reduce anxiety, but long-term impact remains unclear
A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under ...
Knowridge4d
Depression drugs effectively reduce anxiety symptoms
A new review from the Cochrane Database of Systematic Reviews confirms that antidepressants can effectively reduce symptoms ...
clinicaltrialsarena on MSN5d
MindMed doses first subject in Phase III Panorama study of GAD tablet
MindMed has dosed the first subject in the Phase III Panorama study of MM120 ODT for the treatment of generalised anxiety ...
emjreviews.com1d
New Approach to Treating Depression and Anxiety: Virtual Reality Meditation
Virtual reality meditation effectively reduces depression and anxiety symptoms while improving emotional regulation in ...
devdiscourse5d
Personalized therapy for anxiety: The promise of AI-driven healthcare
AI-driven tools harness ML algorithms to provide insights into anxiety disorders. Supervised ML models, such as logistic ...
Health.com7d
How Are Perfectionism and Anxiety Related?
Perfectionism is often elevated in anxiety disorders. These include generalized anxiety disorder (GAD), social anxiety, panic, and post-traumatic stress disorder (PTSD). The fear of being judged ...
MindMed's LSD Anxiety Drug: Revisiting, Rethinking, But Maintaining My 'Hold' Call
Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.
MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder
Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product ...
Optimistic Buy Rating for Mind Medicine’s MM120 Amid Promising Phase 3 Progress and Strong Phase 2b Results
Patrick Trucchio, an analyst from H.C. Wainwright, reiterated the Buy rating on Mind Medicine (MNMD – Research Report). The associated price ...
News Medical on MSN6d
Antidepressants reduce anxiety, but long-term impact remains unclear
A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.